Learn if You Have a Claim Against Biomedical Tissue Services

Patients Sue Over Tainted Tissue

A class action lawsuit was filed in federal court in Baton Rouge that claims a New York medical supply company sold illegal tissue and bone to Baton Rouge hospital Our Lady of the Lake Regional Medical Center and other unnamed hospitals in Louisiana. Darrel Bourque says surgeons notified him in January that tissue transplanted in his neck during spinal surgery a year ago came from Biomedical Tissue Services.

Please explain any problems you have had in relation to this case:

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Residents of Eunice, Louisiana, Settle Train Derailment Action with Union Pacific for $65 Million

The parties have reached a tentative $65 million settlement in an action filed against Union Pacific Corporation on behalf of thousands of evacuees who were forced to leave their homes in Eunice, Louisiana, after a train derailment on May 27, 2000. Persons eligible to take part in the settlement should contact attorneys for the class for more information.

Manhattan Trio Drugs Pharmacy Users Allege Privacy Violations in Records Sale to CVS

State and federal privacy laws protect your confidential records from sale and use in many situations. A class action has been filed against CVS Corporation, Trio Drugs Corporation, and Manhattan pharmacist Gerald Hinderstein on behalf of pharmacy customers who allege that Trio and its pharmacist violated their fiduciary duties to their customers and committed deceptive business practices when they sold prescription drug records to CVS.

Florida Supreme Court Revisits $145 Billion Judgment Against Tobacco Companies

The Florida Supreme Court has decided to review an appeals court ruling that overturned the $145 billion judgment against major tobacco companies on behalf of current and former Floridian smokers. The action alleges that the cigarette companies deceived the public about the health dangers of cigarettes, in violation a state consumer protection laws. Persons eligible to take part in the action can stay updated through ClassActionAmerica’s case-tracking services.

Seattle Firm Files Class Action Over Serostim Prescription

Biotech Group Serono SA faces a new class-action law suit in connection with prescriptions of the AIDS drug Serostim. According to a press release, the new lawsuit was filed by a Seattle law firm in a Massachusetts court on behalf of health insurer GEHA.

Claims Deadline Nears For Farmers Insureds

Eligible motorists and health care providers have until Monday December 6th to claim a share in a $9.5 million jury verdict against Farmers Insurance. The verdict against Farmers was returned in a class action lawsuit in Multnomah County Circuit Court on December 5, 2003. Class members, eligible for a share of the jury award, include people who were injured in a motor vehicle accident between January 26, 1998 and July 31, 1999 and had a claim with Farmers Insurance. Also eligible for a share of the award are the doctors and medical clinics that treated the injured individuals. All claims must be postmarked no later than December 6, 2004. So far approximately 3000 individuals have filed claims. The benefits available are estimated at $207.00 per claimant.

Drug Manafacturer Impax Laboratories Accused of Inflating Earnings Reports

A class action has been filed against drug manufacturer Impax Laboratories, Inc. (Nasdaq:IPXL) and certain of its officers and directors by stockholders who purchased the company’s common stock between May 5, 2004 and November 3, 2004. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company’s securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.